+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Minocycline Hydrochloride Market - Global Forecast 2025-2030 - Product Thumbnail Image

Minocycline Hydrochloride Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
From
Piroxicam Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Piroxicam Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Triamcinolone Tablets Market - Global Forecast to 2030 - Product Thumbnail Image

Triamcinolone Tablets Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Piroxicam Patches Market - Global Forecast 2025-2030 - Product Thumbnail Image

Piroxicam Patches Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
From
From
Systemic Lupus Erythematosus Market - Global Forecast 2025-2032 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 180 Pages
  • Global
From
Lodine Tincture Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lodine Tincture Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Treg Cell-Based Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Treg Cell-Based Therapies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Endometriosis- Pipeline Insight, 2025 - Product Thumbnail Image

Endometriosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) - Pipeline Insight, 2025 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more